BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8430546)

  • 21. Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer.
    ; Shihab OC; Taylor F; Bees N; Blake H; Jeyadevan N; Bleehen R; Blomqvist L; Creagh M; George C; Guthrie A; Massouh H; Peppercorn D; Moran BJ; Heald RJ; Quirke P; Tekkis P; Brown G
    Br J Surg; 2011 Dec; 98(12):1798-804. PubMed ID: 21928408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urologic reconstruction within the scope of interdisciplinary pelvic exenteration for treatment of invasive tumors of the pelvis].
    Aleksic M; von Heyden U; Ulrich B; Schmitz-Dräger BJ
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1497-8. PubMed ID: 9931923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of pelvic exenteration for sarcomatous malignancies.
    Reid GC; Morley GW; Schmidt RW; Hopkins MP
    Obstet Gynecol; 1989 Jul; 74(1):80-4. PubMed ID: 2733946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer.
    Akasu T; Iinuma G; Takawa M; Yamamoto S; Muramatsu Y; Moriyama N
    Ann Surg Oncol; 2009 Oct; 16(10):2787-94. PubMed ID: 19618244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer.
    Han SS; Lee SH; Kim DH; Kim JW; Park NH; Kang SB; Song YS
    Acta Obstet Gynecol Scand; 2010; 89(2):168-74. PubMed ID: 19916890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of the Role of Imaging in Pelvic Exenteration.
    Sagebiel TL; Viswanathan C; Patnana M; Devine CE; Frumovitz M; Bhosale PR
    Radiographics; 2015; 35(4):1286-94. PubMed ID: 26172363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative assessment of complete tumour resection by magnetic resonance imaging in patients undergoing pelvic exenteration.
    Forner DM; Meyer A; Lampe B
    Eur J Obstet Gynecol Reprod Biol; 2010 Feb; 148(2):182-5. PubMed ID: 19919889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
    Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
    AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR imaging of pelvic masses in women: contrast-enhanced vs unenhanced images.
    Thurnher SA
    AJR Am J Roentgenol; 1992 Dec; 159(6):1243-50. PubMed ID: 1442393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postirradiation changes in the pelvis: assessment with MR imaging.
    Sugimura K; Carrington BM; Quivey JM; Hricak H
    Radiology; 1990 Jun; 175(3):805-13. PubMed ID: 2343132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rectal Cancer: MR imaging of the mesorectal fascia and effect of chemoradiation on assessment of tumor involvement.
    Oberholzer K; Junginger T; Heintz A; Kreft A; Hansen T; Lollert A; Ebert M; Düber C
    J Magn Reson Imaging; 2012 Sep; 36(3):658-63. PubMed ID: 22592948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological assessment of the interface between tumor and neighboring tissues, by magnetic resonance imaging, before and after radiotherapy in patients with locally advanced rectal cancer.
    Torkzad MR; Suzuki C; Tanaka S; Palmer G; Holm T; Blomqvist L
    Acta Radiol; 2008 Dec; 49(10):1099-103. PubMed ID: 19031179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Robotic radical anterior pelvic exenteration: the UCI experience.
    Kaufmann OG; Young JL; Sountoulides P; Kaplan AG; Dash A; Ornstein DK
    Minim Invasive Ther Allied Technol; 2011 Jul; 20(4):240-6. PubMed ID: 21142832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vagina: evaluation with MR imaging. Part II. Neoplasms.
    Chang YC; Hricak H; Thurnher S; Lacey CG
    Radiology; 1988 Oct; 169(1):175-9. PubMed ID: 3420257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pelvic exenteration with curative intent for recurrent uterine malignancies.
    Khoury-Collado F; Einstein MH; Bochner BH; Alektiar KM; Sonoda Y; Abu-Rustum NR; Brown CL; Gardner GJ; Barakat RR; Chi DS
    Gynecol Oncol; 2012 Jan; 124(1):42-7. PubMed ID: 22014627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis.
    Mir N; Sohaib SA; Collins D; Koh DM
    J Med Imaging Radiat Oncol; 2010 Aug; 54(4):358-64. PubMed ID: 20718916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period.
    Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y
    Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fast spin-echo MR images of the pelvis obtained with a phased-array coil: value in localizing and staging prostatic carcinoma.
    Kier R; Wain S; Troiano R
    AJR Am J Roentgenol; 1993 Sep; 161(3):601-6. PubMed ID: 8352116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, MRI, and PET-CT criteria used by surgeons to determine suitability for pelvic exenteration surgery for recurrent rectal cancers: a Delphi study.
    Chew MH; Brown WE; Masya L; Harrison JD; Myers E; Solomon MJ
    Dis Colon Rectum; 2013 Jun; 56(6):717-25. PubMed ID: 23652745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
    Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
    Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.